Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer.

J Gynecol Oncol · 2020 · PMC7044004 · PMID 31912678

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Recently, an improved survival of ddPC in NAC setting has been suggested by Becker et al., [ 9 ] alongside a favorable trend towards pathologic complete remission.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.